Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Molecular mapping of interstitial lung disease reveals a phenotypically distinct senescent basal epithelial cell population
Daryle J. DePianto, … , Paul J. Wolters, Joseph R. Arron
Daryle J. DePianto, … , Paul J. Wolters, Joseph R. Arron
Published March 11, 2021
Citation Information: JCI Insight. 2021;6(8):e143626. https://doi.org/10.1172/jci.insight.143626.
View: Text | PDF
Research Article Aging Pulmonology

Molecular mapping of interstitial lung disease reveals a phenotypically distinct senescent basal epithelial cell population

  • Text
  • PDF
Abstract

Compromised regenerative capacity of lung epithelial cells can lead to cellular senescence, which may precipitate fibrosis. While increased markers of senescence have been reported in idiopathic pulmonary fibrosis (IPF), the origin and identity of these senescent cells remain unclear, and tools to characterize context-specific cellular senescence in human lung are lacking. We observed that the senescent marker p16 is predominantly localized to bronchiolized epithelial structures in scarred regions of IPF and systemic sclerosis–associated interstitial lung disease (SSc-ILD) lung tissue, overlapping with the basal epithelial markers Keratin 5 and Keratin 17. Using in vitro models, we derived transcriptional signatures of senescence programming specific to different types of lung epithelial cells and interrogated these signatures in a single-cell RNA-Seq data set derived from control, IPF, and SSc-ILD lung tissue. We identified a population of basal epithelial cells defined by, and enriched for, markers of cellular senescence and identified candidate markers specific to senescent basal epithelial cells in ILD that can enable future functional studies. Notably, gene expression of these cells significantly overlaps with terminally differentiating cells in stratified epithelia, where it is driven by p53 activation as part of the senescence program.

Authors

Daryle J. DePianto, Jason A. Vander Heiden, Katrina B. Morshead, Kai-Hui Sun, Zora Modrusan, Grace Teng, Paul J. Wolters, Joseph R. Arron

×

Figure 1

Expression of the senescent marker p16 (CDKN2A) is induced in IPF and SSc-ILD, where it localizes to basal epithelial cells in bronchiolized epithelium.

Options: View larger image (or click on image) Download as PowerPoint
Expression of the senescent marker p16 (CDKN2A) is induced in IPF and SS...
(A) Microarray analysis of CDKN2A gene expression (mean ± SD, control n = 8, IPF n = 40) in control and IPF lung tissue. ***P < 0.005 (unpaired 2-tailed Student’s t tests). (B) RNA-Seq data for CDKN2A gene expression (mean ± SD, control n = 4, IPF n = 10, SSc-ILD n = 3) in control, IPF, and SSc-ILD lung tissue explants. ***P < 0.005 (Tukey’s multiple comparisons test). nRPKM, normalized reads per kilobase gene model per million total reads. (C) Top 50 correlates with CDKN2A gene expression in control and IPF lung tissue, sample set from A. (D) H&E (top row) and immunohistochemical staining of control, IPF, and SSc-ILD lung tissue sections for p16 protein. Highlighted regions from H&E shown at higher magnification from immunostainings of serial sections. (E) Serial sections of lung tissue stained for p16 and KRT17 proteins. (F) Costaining of IPF lung tissue sections for p16/SP-C and p16/KRT5 proteins. Scale bars: 200 μm (H&E), 50 μm (enlarged) (D); 50 μm (E); 100 μm (F).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts